SSI Diagnostica (Adelis) Acquires TECHLAB, Inc. from Pharos Capital
August 22, 2022
SSI Diagnostica, a portfolio company of Adelis Equity, has acquired TECHLAB, Inc. from Pharos Capital Group. The acquisition combines SSI Diagnostica's global distribution and production capabilities with TECHLAB's U.S. R&D and manufacturing to grow the combined diagnostics business; TECHLAB will continue operating from its Virginia facilities and retain its management team and workforce.
- Buyers
- SSI Diagnostica, Adelis Equity
- Targets
- TECHLAB, Inc.
- Sellers
- Pharos Capital Group
- Industry
- Medical Devices
- Location
- Virginia, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
SSI Diagnostica Group Acquires InDevR
February 3, 2026
Healthcare Services
SSI Diagnostica Group has announced the acquisition of InDevR, a Colorado-based provider of multiplexed solutions for vaccine testing and quality control. The deal is intended to strengthen SSI’s leadership in pneumococcal vaccine QC testing by adding next-generation multiplexing assays, influenza and mRNA vaccine QC expertise, and related analytical software capabilities.
-
SSI Diagnostica Group Acquires Gulf Coast Scientific
April 28, 2025
Medical Devices
SSI Diagnostica Group (Denmark) has acquired Gulf Coast Scientific, a Florida-based in‑vitro diagnostics company specializing in Urea Breath Testing for Helicobacter pylori. The deal expands SSI Diagnostica Group's gastrointestinal diagnostic portfolio and strengthens its footprint in the US clinical diagnostics market.
-
Charles River Laboratories Acquires SAMDI Tech
January 30, 2023
Biotechnology
Charles River Laboratories acquired the remaining 80% stake in SAMDI Tech for $50 million in cash, completing a transaction that follows a partnership begun in 2018. The acquisition integrates SAMDI Tech's proprietary mass spectrometry high-throughput screening technology into Charles River's Discovery and Safety Assessment segment to strengthen drug discovery capabilities and accelerate hit identification for pharmaceutical and biotech clients.
-
Quest Diagnostics Acquires Labtech Diagnostics
December 14, 2021
Healthcare Services
Quest Diagnostics has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory based in Anderson, South Carolina. The acquisition brings Labtech into Quest’s national laboratory network — Quest’s first full-service laboratory in South Carolina — and expands Quest’s diagnostic capabilities and presence across the Southeast.
-
Adelis Equity Partners Becomes Majority Owner of Nordic BioSite Group
May 28, 2021
Healthcare Services
Adelis Equity Partners has acquired a majority stake in Nordic BioSite Group to accelerate the group's growth and pan‑European expansion of its life‑science research and diagnostics distribution platform. Tellacq Partners, together with the founders and management team, had built the group (including Nordic Biosite AB, Sanbio BV and Biomol GmbH); the parties did not disclose the purchase price.
-
SSI Diagnostica (Adelis portfolio) Acquires CTK Biotech
August 26, 2020
Medical Devices
Adelis Equity Partners portfolio company SSI Diagnostica has acquired US-based CTK Biotech to create a global rapid diagnostics leader focused on respiratory and tropical disease tests. The deal combines SSI Diagnostica's Nordic IVD capabilities and distribution with CTK's product development and manufacturing (headquartered in San Diego with a manufacturing plant in Beijing), and triggers a CEO change and several board appointments.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.